LORAZEPAM INJECTION USP
SANDOZ CANADA INCORPORATED
Quick answers
Is there a shortage of LORAZEPAM INJECTION USP in Canada?
No. There is no current shortage of LORAZEPAM INJECTION USP 4MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
ATIVAN INJECTION LIQ 4MG/ML
WYETH CANADA
ATIVAN INJ 4MG/ML
WYETH LTD.
ATIVAN SUBL TAB 1MG
WYETH LTD.
TEVA-LORAZEPAM
TEVA CANADA LIMITED
ATIVAN TAB 1MG
WYETH LTD.
PRO-LORAZEPAM
PRO DOC LIMITEE
DIN
02243278
Strength
4MG
Dosage Form
SOLUTION LIQUID
Route
INTRAVENOUS INTRAMUSCULAR
Compare with another product →
Shortage History
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495910
DIN 02495937
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759